Latest News Public health

02 March 2026

Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2026 Virtual Animal Health Summit.

Chief Financial Officer, Glenn David; Chief Operating Officer, Larry Miller and Executive Vice President, Corporate Strategy and CEO designate Daniel Bendheim will address financial analysts and investors on Thursday, February 26, 2026, at 10:45 AM ET.

The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A replay of the session will be available and archived on the company’s website.

About Phibro Animal Health Corporation

About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals.

Source: www.pahc.com

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Discretionary donations support research, students and clinical care

A multicenter prospective evaluation of owner medication adherence for feline cardiovascular disease in the referral setting

Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia and Duodenal Perforation in a 1-Year-Old British Shorthair Cat

Grant to Treat Oncology Patients Saves Dog’s Leg

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit

Comments

List

Add

Tag

Related Articles

24 October 2025
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs

Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs

06 June 2025
Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference

Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference

06 November 2024
Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products

Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products

30 October 2023
Zinpro® Corporation Expands Manufacturing Operations with New Brazil Plant

Zinpro® Corporation Expands Manufacturing Operations with New Brazil Plant

01 July 2022
Neogen launches insect solution for poultry

Neogen launches insect solution for poultry

More news

Meet Dr. Stephanie Maciorowski

Parnell Launches Pentobarbital Sodium and Phenytoin Sodium Euthanasia Solution for Dogs

Implementing a successful senior/geriatric health care program for veterinarians, veterinary technicians, and office managers

Malassezia species and its significance in canine skin disease

Assessment of serum amyloid A testing of horses and its clinical application in a specialized equine practice

Newsletter